253 related articles for article (PubMed ID: 17944913)
21. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.
Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A
PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777
[TBL] [Abstract][Full Text] [Related]
22. LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis.
Shigaki H; Baba Y; Watanabe M; Murata A; Iwagami S; Miyake K; Ishimoto T; Iwatsuki M; Baba H
Gastric Cancer; 2013 Oct; 16(4):480-7. PubMed ID: 23179365
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.
Notaro S; Reimer D; Fiegl H; Schmid G; Wiedemair A; Rössler J; Marth C; Zeimet AG
BMC Cancer; 2016 Aug; 16():589. PubMed ID: 27485273
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.
Bhagat R; Kumar SS; Vaderhobli S; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 Sep; 35(9):9069-78. PubMed ID: 24913706
[TBL] [Abstract][Full Text] [Related]
25. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiles as prognostic markers in women with ovarian cancer.
Jochumsen KM; Tan Q; Høgdall EV; Høgdall C; Kjaer SK; Blaakaer J; Kruse TA; Mogensen O
Int J Gynecol Cancer; 2009 Oct; 19(7):1205-13. PubMed ID: 19823056
[TBL] [Abstract][Full Text] [Related]
27. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
28. Application of multiplex nested methylated specific PCR in early diagnosis of epithelial ovarian cancer.
Wang B; Yu L; Yang GZ; Luo X; Huang L
Asian Pac J Cancer Prev; 2015; 16(7):3003-7. PubMed ID: 25854397
[TBL] [Abstract][Full Text] [Related]
29. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.
Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J
Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226
[TBL] [Abstract][Full Text] [Related]
30. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
[TBL] [Abstract][Full Text] [Related]
31. Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.
Vo LT; Thuan TB; Thu DM; Uyen NQ; Ha NT; To TV
Asian Pac J Cancer Prev; 2013; 14(12):7713-8. PubMed ID: 24460357
[TBL] [Abstract][Full Text] [Related]
32. A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation.
Guerrero K; Wang Z; Bachvarova M; Gregoire J; Renaud MC; Plante M; Bachvarov D
Gynecol Oncol; 2012 Jun; 125(3):720-6. PubMed ID: 22446619
[TBL] [Abstract][Full Text] [Related]
33. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer.
Xu YZ; Xi QH; Ge WL; Zhang XQ
Asian Pac J Cancer Prev; 2013; 14(2):1057-60. PubMed ID: 23621186
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic biomarkers in epithelial ovarian cancer.
Gloss BS; Samimi G
Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
[TBL] [Abstract][Full Text] [Related]
35. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.
Tas F; Kilic L; Bilgin E; Keskin S; Sen F; Ciftci R; Yildiz I; Yasasever V
Int J Gynecol Cancer; 2013 Feb; 23(2):276-81. PubMed ID: 23266651
[TBL] [Abstract][Full Text] [Related]
37. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.
Chalitchagorn K; Shuangshoti S; Hourpai N; Kongruttanachok N; Tangkijvanich P; Thong-ngam D; Voravud N; Sriuranpong V; Mutirangura A
Oncogene; 2004 Nov; 23(54):8841-6. PubMed ID: 15480421
[TBL] [Abstract][Full Text] [Related]
38. Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers.
Baba Y; Yagi T; Sawayama H; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H
Digestion; 2018; 97(1):26-30. PubMed ID: 29393154
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.
Ramzy II; Omran DA; Hamad O; Shaker O; Abboud A
Arab J Gastroenterol; 2011 Sep; 12(3):139-42. PubMed ID: 22055592
[TBL] [Abstract][Full Text] [Related]
40. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]